Natco Pharma wins FDA approval for generic colorectal cancer drug
Indian pharmaceutical firm Natco Pharma has gained the US Food and Drug Administration (FDA)’s final approval for its abbreviated new drug application (ANDA) for Tipiracil Hydrochloride and Trifluridine Tablets, the generic version of Lonsurf. The original drug, produced by Taiho Oncology Inc., is primarily used for treating colorectal cancer. Natco Pharma’s potential First-to-File status for […]